- Home
- ATYR vs URG Comparison
ATYR vs URG Comparison
Compare ATYR & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | URG |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 594.4M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ATYR | URG |
|---|---|---|
| Price | $0.75 | $1.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $4.20 | $2.46 |
| AVG Volume (30 Days) | 985.5K | ★ 7.8M |
| Earning Date | 03-05-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,207,000.00 |
| Revenue This Year | N/A | $200.42 |
| Revenue Next Year | N/A | $98.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.55 |
| 52 Week High | $7.29 | $2.35 |
Technical Indicators
Market Signals| Indicator | ATYR | URG |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 42.81 |
| Support Level | $0.67 | $1.14 |
| Resistance Level | $0.85 | $1.66 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 1.23 | 31.33 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.